Q: Hi 5i,
Just wondering if you knew how PKI's share offering was moving along? Do you know if it was well received, or was it under subscribed? I'm wondering if the share price will drop after the closing date and if I could get a better price on it.
Q: In a response to SIS' recent acquisition, you noted it was "30% accretive to financial metrics". I've seen a similar term used in other responses regarding acquisitions. What exactly does this mean, and what amount of "accretion" is considered good in an acquisition? Thanks
Q: Hello,
How do subscription receipts work? How do you purchase them? Do you think the subscription receipts coming for SIS are a good investment? Thanks Luke
Q: I notice that Savaria Corp is having its annual meeting on May 15. They have also called it a special meeting. Could you elaborate on the reasons why a "special meeting" would be held? Thanks!
I would like to start a new full position in an non-registered account. What would be your suggestions at the moment for growth and long-term (5-10 years+)?
Q: Back around the New Year, there was much concern about TOY and the reaction to consumers complaining about the Hatchimals they purchased as gifts. 5i suggested patience and reiterated their confidence that TOY management would resolve the issues. I thought, therefore, that it might be worth noting the following comments made by the lawyers for the plaintiffs who had filed a class action lawsuit that was withdrawn a could of weeks ago.
"Mark Geragos, the lawyer who voluntarily withdrew the law suit on behalf of the plaintiff added, "Spin Master's proactive response was very successful and, to date, they have either responded to all of the outstanding questions or provided replacements, or refunds to consumers. We applaud Spin Master for the highly effective manner in which they have dealt with their customers. Given these factors, we have decided to voluntarily withdraw our class action."
This speaks highly - again - to the quality of advice we members receive from you. TOY is now trading at all-time highs.
As when anything goes wrong in a specific industry such as HCG and mortgages, many companies may be tarred with the same brush. Is there any company that has fallen just being in the same space as HCG that may be a good under valuation buy? Thank-you
I will like your assistance on guiding my investment decision. I have read your report on Knight Therapeutics. After Knight has deployed its war chest($736,000,000), you are forecasting earnings per share of $0.59, plus the EPS for the last quarterly report of 0.06$. If earnings grow at 15% per year for the next 5 years, then in 2022, EPS will be :
2017 2018 2019 2020 2021 2022
$0.65 $0.75 $0.86 $0.99 $1.14 $1.31
I am assuming cash is deployed this year, the share count remains constant and investors in 2022 are willing to pay 15 times EPS. If this scenario holds, then in 2022, the share price should trade at around $20 (1.31 X 15). At current price ($10.60), this scenario would result in an annual rate of return for the next five years of 13.1%. Are you comfortable with my scenario or would you change some of my parameters ?
Q: I own some Home Trust notes ( due May17 and Dec18). Are these at risk? Why has the price dropped if they
are due in only a few weeks, is this a bond market looking to take advantage of fear?